Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

<< Previous

Bullboard Posts

Next >>

Comment by Mork102on Apr 01, 2024 7:17am

75 Views

Post# 35962308

RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

Obviously you haven't been a shareholder for long
the announcements of health Canada approval sent the stock to over 30 cents
however not a single solitary sale
lots of hype from management but never any substance
i stopped accumulating last year and refused to be sucked into the PP at 8 cents
those that bought at 7 cents last year are not winners

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals